They found that in immunodeficient mice transplanted with OS cells, NK cells expressing the NKG2D-DAP10-CD3z receptor had great antitumor activity and produced significant tumor reduction, while the simulated transduction-activated NK cells were ineffective [99]. The gene discussed is KLRK1; the disease is neoplasm.